1. Home
  2. TLSI vs HITI Comparison

TLSI vs HITI Comparison

Compare TLSI & HITI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSI
  • HITI
  • Stock Information
  • Founded
  • TLSI 2010
  • HITI 2009
  • Country
  • TLSI United States
  • HITI Canada
  • Employees
  • TLSI N/A
  • HITI N/A
  • Industry
  • TLSI Medical Specialities
  • HITI
  • Sector
  • TLSI Health Care
  • HITI
  • Exchange
  • TLSI Nasdaq
  • HITI Nasdaq
  • Market Cap
  • TLSI 150.0M
  • HITI 178.6M
  • IPO Year
  • TLSI N/A
  • HITI N/A
  • Fundamental
  • Price
  • TLSI $4.80
  • HITI $3.57
  • Analyst Decision
  • TLSI Strong Buy
  • HITI Strong Buy
  • Analyst Count
  • TLSI 5
  • HITI 2
  • Target Price
  • TLSI $10.90
  • HITI $4.75
  • AVG Volume (30 Days)
  • TLSI 95.6K
  • HITI 1.3M
  • Earning Date
  • TLSI 11-13-2025
  • HITI 09-15-2025
  • Dividend Yield
  • TLSI N/A
  • HITI N/A
  • EPS Growth
  • TLSI N/A
  • HITI N/A
  • EPS
  • TLSI N/A
  • HITI N/A
  • Revenue
  • TLSI $35,990,000.00
  • HITI $410,600,094.00
  • Revenue This Year
  • TLSI $56.79
  • HITI $12.28
  • Revenue Next Year
  • TLSI $54.15
  • HITI $21.83
  • P/E Ratio
  • TLSI N/A
  • HITI N/A
  • Revenue Growth
  • TLSI 45.50
  • HITI 11.18
  • 52 Week Low
  • TLSI $3.42
  • HITI $1.64
  • 52 Week High
  • TLSI $5.88
  • HITI $3.99
  • Technical
  • Relative Strength Index (RSI)
  • TLSI 51.02
  • HITI 63.25
  • Support Level
  • TLSI $4.41
  • HITI $3.24
  • Resistance Level
  • TLSI $4.93
  • HITI $3.99
  • Average True Range (ATR)
  • TLSI 0.28
  • HITI 0.20
  • MACD
  • TLSI -0.05
  • HITI -0.01
  • Stochastic Oscillator
  • TLSI 42.25
  • HITI 50.00

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.

Share on Social Networks: